FENHANCE · GN41851
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with teriflunomide in adult patients with relapsing multiple sclerosis. EudraCT: 2019-004857-10
Sponsor: ROCHE
Phase: III
Area: Neuroimmunology